Cargando…
Carbamazepine degradation by visible-light-driven photocatalyst Ag(3)PO(4)/GO: Mechanism and pathway
Carbamazepine (CBZ), as one of the most frequently detected pharmaceuticals, is of great concern due to its potential impact on the ecosystem and human health. This study provides an effective approach to remove CBZ by using photocatalyst silver phosphate combined with graphene oxide (Ag(3)PO(4)/GO)...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488069/ https://www.ncbi.nlm.nih.gov/pubmed/36157857 http://dx.doi.org/10.1016/j.ese.2021.100143 |
Sumario: | Carbamazepine (CBZ), as one of the most frequently detected pharmaceuticals, is of great concern due to its potential impact on the ecosystem and human health. This study provides an effective approach to remove CBZ by using photocatalyst silver phosphate combined with graphene oxide (Ag(3)PO(4)/GO) under visible irradiation. The morphology, composition, and optical properties of Ag(3)PO(4)/GO were characterized employing SEM, XRD, and DRS. Graphene oxide could improve the visible-light utilization and promote electron's charge to enhance the photocatalytic performance of Ag(3)PO(4)/GO. With the optimal reaction condition of 5.86 mW/cm(2) light intensity, 15–25 °C temperature, 5–7 pH, and 0.5 mg/L catalytic dosages, 5 mg/L CBZ could be completely degraded in 30 min, and the apparent rate constant could reach 0.12 min(−1). Additionally, the radical trapping experiments indicated •OH and O(2)ˉ• were the main reactive oxygen species employed to eliminate CBZ. The decay pathways of CBZ had been proposed accordingly, and the main product was the low-molecular products. |
---|